Mark Horowitz
Glenview Capital Management, Llc
Assets Managed
$3.983B
Holdings
43
Last Quarter
2026 - Q1
Filed Date
11d ago
Growth Rate
-18.94%(2Q avg: -4.77%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Glenview Capital Management, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 43 positions.
Assets under management
The assets under management (AUM) of Glenview Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 3.983B in assets, with a quarterly growth rate of -18.94% and a 2-quarter average growth rate of -4.77%. The portfolio is managed by Mark Horowitz, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
CVS Cvs Health Corp
| 14.78% | $588.694M 8.197M shares@ $71.82 avg price | |
GPN Global Payments Inc
| 10.92% | $434.784M 6.46M shares@ $67.31 avg price | Increased 9.11% |
THC Tenet Healthcare Corp
| 7.23% | $287.755M 1.525M shares@ $188.71 avg price | Decreased -23.13% |
AMZN Amazon.com Inc
| 5.54% | $220.614M 1.059M shares@ $208.28 avg price | Increased 16.5% |
TEVA Teva Pharmaceutical-sp Adr
| 5.04% | $200.606M 6.66M shares@ $30.12 avg price | Decreased -60.16% |
QQQ Invesco Qqq Trust Series 1
| 4.76% | $189.43M↑ Call 328,200 shares@ $577.18 avg price | New Position |
CI The Cigna Group
| 3.35% | $133.066M 498,841 shares@ $266.76 avg price | Increased 78.57% |
AMD Advanced Micro Devices
| 3.33% | $132.391M 650,792 shares@ $203.44 avg price | Increased 65.1% |
TMO Thermo Fisher Scientific Inc
| 3.1% | $123.141M 250,525 shares@ $491.53 avg price | Increased 11.87% |
VTRS Viatris Inc
| 3.09% | $122.769M 9.087M shares@ $13.51 avg price | Decreased -18.03% |
1-10 of 43